Study: Oral HCV drugs are best for untreated patients

03/6/2013 | MedPage Today (free registration)

Tests of fully oral drug regimens for hepatitis C showed they cured up to 95% of previously untreated patients but only 47% of those whose earlier therapy had failed, a University of Texas researcher reported. None of the patients were given pegylated interferon, which has been a standard HCV treatment but is difficult for patients to tolerate.

View Full Article in:

MedPage Today (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care